| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.454 | 3.954 | 7.251 | 7.001 | 9.305 | 15.040 | 12.777 | 18.604 | 26.813 | 26.354 |
| Total Income - EUR | 2.514 | 4.047 | 7.300 | 7.093 | 9.382 | 15.154 | 12.777 | 18.604 | 26.813 | 26.354 |
| Total Expenses - EUR | 4.380 | 4.316 | 8.401 | 5.404 | 7.556 | 11.923 | 10.577 | 15.179 | 22.375 | 21.520 |
| Gross Profit/Loss - EUR | -1.866 | -270 | -1.101 | 1.689 | 1.826 | 3.231 | 2.200 | 3.425 | 4.437 | 4.834 |
| Net Profit/Loss - EUR | -1.941 | -391 | -1.318 | 1.476 | 1.545 | 2.807 | 1.817 | 2.928 | 3.754 | 4.113 |
| Employees | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alessia Fitofarmacie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 575 | 569 | 559 | 549 | 538 | 528 | 516 | 518 | 516 | 513 |
| Current Assets | 4.944 | 8.441 | 8.481 | 12.211 | 12.617 | 13.942 | 19.941 | 27.838 | 33.564 | 37.675 |
| Inventories | 4.847 | 8.205 | 7.918 | 9.829 | 12.138 | 13.821 | 19.812 | 27.652 | 33.398 | 37.559 |
| Receivables | 0 | 117 | 410 | 403 | 395 | 0 | 0 | 1 | 81 | 74 |
| Cash | 97 | 119 | 153 | 1.979 | 83 | 122 | 129 | 185 | 85 | 42 |
| Shareholders Funds | -1.896 | -2.268 | -3.548 | -2.007 | -423 | 2.393 | 4.157 | 7.097 | 10.829 | 14.882 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.415 | 11.278 | 12.588 | 14.767 | 13.578 | 12.078 | 16.301 | 21.259 | 23.251 | 23.307 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Alessia Fitofarmacie Srl